Education
About Us
Working with TipRanks
Follow Us
Nucana Plc (NCNA)
:NCNA
NCNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.79 - $10.79
Previous CloseN/A
Volume88.96K
Average Volume (3M)46.56K
Market Cap
$3.21M
Enterprise Value-$9.37M
Total Cash (Recent Filing)£76.97M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.86
Next Earnings
May 14, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.90
Shares Outstanding2,266,430
10 Day Avg. Volume27,071
30 Day Avg. Volume46,558
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nucana News
PremiumPre-Earnings
Is NCNA a Buy, Before Earnings?
PremiumCompany Announcements
Nucana Reports Third Quarter Loss Amid R&D Investments
PremiumCompany Announcements
NuCana’s NUC-3373 Shows Promise in Cancer Treatment
PremiumCompany Announcements
NuCana plc Enhances Offering to $5.4 Million---
Ownership Overview
11.00%
Insiders
0.03% Mutual Funds
9.96% Other Institutional Investors
79.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NCNA FAQ
What was Nucana Plc’s price range in the past 12 months?
Nucana Plc lowest stock price was $0.79 and its highest was $10.79 in the past 12 months.
What is Nucana Plc’s market cap?
Nucana Plc’s market cap is $3.21M.
When is Nucana Plc’s upcoming earnings report date?
Nucana Plc’s upcoming earnings report date is May 14, 2025 which is in 62 days.
How were Nucana Plc’s earnings last quarter?
Currently, no data Available
Is Nucana Plc overvalued?
According to Wall Street analysts Nucana Plc’s price is currently Overvalued.
Does Nucana Plc pay dividends?
Nucana Plc does not currently pay dividends.
What is Nucana Plc’s EPS estimate?
Nucana Plc’s EPS estimate is -0.08.
How many shares outstanding does Nucana Plc have?
Nucana Plc has 2,266,430 shares outstanding.
What happened to Nucana Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nucana Plc?
Currently, no hedge funds are holding shares in NCNA
---
Company Description
Nucana Plc
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
---
NCNA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Alnylam Pharma
―
Fate Therapeutics
―
Sorrento Therapeutics
―
Adaptimmune Therapeutics
―
Kura Oncology
―
Best Analysts Covering NCNA
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-54.18%
reiterated a buy rating 6 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -54.18% per trade.
---